Xeris Biopharma Holdings, Inc. (XERS) › Shareholders' EquityXeris Biopharma Holdings, Inc. (XERS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $14.44M2020: $33.76M2021: $95.23M2022: $45.19M2023: -$6.78M2024: -$29.61M2025: $13.69M$13.69M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$13.69M+146.2%2024-$29.61M-336.7%2023-$6.78M-115.0%2022$45.19M-52.6%2021$95.23M+182.1%2020$33.76M+133.9%2019$14.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share